Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sleep disturbances are underappreciated in prostate cancer survivorship.
Gong F, Loeb S, Siu K, Myrie A, Orstad S, Kenfield SA, Morgans A, Thakker S, Robbins R, Carter P, Jean-Louis G, Nolasco TS, Byrne N, Gupta N. Gong F, et al. Among authors: gupta n. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):210-212. doi: 10.1038/s41391-022-00630-6. Epub 2022 Dec 21. Prostate Cancer Prostatic Dis. 2023. PMID: 36543892
Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy.
Gupta N, Kucirka LM, Semerjian A, Wainger J, Pierorazio PM, Herati AS, Bivalacqua TJ. Gupta N, et al. J Sex Med. 2020 May;17(5):949-956. doi: 10.1016/j.jsxm.2020.01.025. Epub 2020 Mar 12. J Sex Med. 2020. PMID: 32171630
CONCLUSION: Future efforts should be directed towards reducing barriers to sexual health counseling of patients undergoing RC to improve deficiencies and gender disparities. Gupta N, Kucirka LM, Semerjian A, et al. Comparing Provider-Led Sexual Health Counseling of …
CONCLUSION: Future efforts should be directed towards reducing barriers to sexual health counseling of patients undergoing RC to improve def …
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.
Hanley MJ, Zhang S, Griffin R, Zhu SX, Fram RJ, Lin J, Venkatakrishnan K, Gupta N. Hanley MJ, et al. Among authors: gupta n. Invest New Drugs. 2024 May 24. doi: 10.1007/s10637-024-01446-y. Online ahead of print. Invest New Drugs. 2024. PMID: 38789848
Moving the needle for oncology dose optimization: A call for action.
Venkatakrishnan K, Jayachandran P, Seo SK, van der Graaf PH, Wagner JA, Gupta N. Venkatakrishnan K, et al. Among authors: gupta n. CPT Pharmacometrics Syst Pharmacol. 2024 May 22. doi: 10.1002/psp4.13157. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38778466 Free article. No abstract available.
8,240 results